Cargando…
A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target
Antibodies that can neutralize diverse HIV-1 strains develop in ~10–20% of HIV-1 infected individuals, and their elicitation is a goal of vaccine design. Such antibodies can also serve as therapeutics for those who have already been infected with the virus. Structural characterizations of broadly re...
Autores principales: | Parker Miller, Emma, Finkelstein, Maxwell T., Erdman, Molly C., Seth, Paul C., Fera, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472920/ https://www.ncbi.nlm.nih.gov/pubmed/34578355 http://dx.doi.org/10.3390/v13091774 |
Ejemplares similares
-
Analysis of two cooperating antibodies unveils immune pressure imposed on HIV Env to elicit a V3-glycan supersite broadly neutralizing antibody lineage
por: Finkelstein, Maxwell T., et al.
Publicado: (2022) -
Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies
por: Finkelstein, Maxwell T., et al.
Publicado: (2021) -
HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope
por: Fera, Daniela, et al.
Publicado: (2018) -
Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure
por: Ray, Krishanu, et al.
Publicado: (2019) -
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
por: Lacerda, Miguel, et al.
Publicado: (2013)